Saxagliptin
Saxagliptin is a pharmaceutical drug with 85 clinical trials. Currently 1 active trials ongoing. Historical success rate of 95.7%.
Success Metrics
Based on 67 completed trials
Phase Distribution
Phase Distribution
12
Early Stage
5
Mid Stage
59
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
94.4%
67 of 71 finished
5.6%
4 ended early
1
trials recruiting
85
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old
Replication of the SAVOR-TIMI Diabetes Trial in Healthcare Claims
Clinical Trials (85)
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
Effects of Saxagliptin on Adipose Tissue Inflammation in Humans
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old
Replication of the SAVOR-TIMI Diabetes Trial in Healthcare Claims
Effects of DPP-4 Inhibition on Triglycerides
Cognitive Protective Effect of Newer Antidiabetic Drugs
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes
Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune Diabetes
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Saxagliptin and Cardiac Structure and Function
Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation
DPP4inhibitors in Type 1 Diabetes
ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea
Effect of Saxagliptin on EPCs as a Cellular Biomarker for Evaluating Endothelial Dysfunction in Early T2DM Patients
A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes
Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With Metformin
Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 85